Lifordi Immunotherapeutics
$42.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Lifordi Immunotherapeutics is currently valued at N/A as of November 18, 2025. The company has raised a total of $112.0M in funding.
Investment Perspective
Lifordi Immunotherapeutics's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Lifordi Immunotherapeutics Worth in 2025?
As of 2025, Lifordi Immunotherapeutics is valued at N/A, based on the company's Early Stage VC funding round in November 18, 2025. This valuation positions Lifordi Immunotherapeutics as one of the leading private companies in the sector.
Lifordi Immunotherapeutics Valuation History
Lifordi Immunotherapeutics's funding history demonstrates steady growth and investor confidence.
How Lifordi Immunotherapeutics Valuation is Determined
Private company valuations like Lifordi Immunotherapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Lifordi Immunotherapeutics Valuation FAQs
Is Lifordi Immunotherapeutics profitable?
Lifordi Immunotherapeutics has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Lifordi Immunotherapeutics's valuation compare to competitors?
Lifordi Immunotherapeutics is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Lifordi Immunotherapeutics IPO?
Lifordi Immunotherapeutics has not announced plans for an initial public offering. Until an IPO, investors can access Lifordi Immunotherapeutics shares through secondary market platforms.